Asimily, a leading innovator in IoT, OT, and IoMT risk management, announced a partnership with Blood Centers of America (BCA), whose 60+ member and affiliate organizations are responsible for over 50% of the U.S. blood supply. This partnership makes Asimily’s comprehensive Lab, Medical Device, and IoT security and risk management platform directly available to all BCA members, enabling blood centers to protect their critical connected equipment and sensitive data.

Cyber Technology Insights: Silverfort Claims Identity Security with Patented Tech & Rebrand

This partnership addresses protecting the various connected devices in the blood bank ecosystem, from collections through testing and ultimately distribution.

“The security of our members’ operations directly impacts the safety and availability of America’s blood supply,” said Sam Keith, Senior Vice President, Blood Centers of America. “By partnering with Asimily, we’re ensuring our nationwide member organizations have the industry-leading solution to secure their Lab, Medical, and IoT devices and to protect their critical equipment and sensitive data. The Asimily platform’s capabilities, the trust that other healthcare-industry customers have in Asimily, and BCA’s support have made this an ideal solution for securing our operations and protecting the communities we serve. This partnership reflects our commitment to providing our members with proven solutions that strengthen their operations and resilience.”

Asimily’s platform combines comprehensive device visibility, vulnerability management, continuous threat monitoring, and streamlined remediation workflows that are optimized for healthcare and life sciences environments like blood centers. The company has extensive experience securing organizations’ critical healthcare operations, with customers including MemorialCare and Methodist Le Bonheur Healthcare. Asimily is also the top-ranked medical device security solution by Gartner Peer Review Insights.

“Recent security breaches continue to underscore how attractive healthcare and life sciences targets are for cybercriminals—unfortunately, blood centers have been part of that story,” said Mike McDermott, Vice President, Asimily. “Particularly with FDA guidance becoming more specific and urgent for blood centers, Asimily’s technology ensures that all devices and equipment can be monitored for the most current and serious vulnerabilities and threats. With Asimily, blood centers can confidently scale IoT assets with the visibility and continuous monitoring required to protect data thoroughly and efficiently.”

The Asimily platform enables BCA members to:

  • Monitor all connected devices, including critical blood testing and processing equipment
  • Reduce their threat surface by mitigating exploitable vulnerabilities
  • Detect and respond to threats before they impact blood center operations
  • Automate security operations with healthcare-optimized workflows
  • Meet stringent compliance requirements and follow FDA guidance
  • Safeguard sensitive patient data and intellectual property

Cyber Technology Insights: Rhapsody Secures HITRUST e1 Certification Amid New Product Launches

To participate in our interviews, please write to our CyberTech Media Room at news@intentamplify.com

Source – Globenewswire